Detalles de la búsqueda
1.
Parallel discovery of selective and dual inhibitors of tryptophan dioxygenases IDO1 and TDO2 with a newly-modified enzymatic assay.
Bioorg Med Chem
; 39: 116160, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33901770
2.
Discovery and characterisation of hydrazines as inhibitors of the immune suppressive enzyme, indoleamine 2,3-dioxygenase 1 (IDO1).
Bioorg Med Chem
; 21(24): 7595-603, 2013 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24262887
3.
A pilot in vivo study: potential ovarian cancer therapeutic by placental extracellular vesicles.
Biosci Rep
; 43(8)2023 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37503762
4.
Evaluation of Novel Inhibitors of Tryptophan Dioxygenases for Enzyme and Species Selectivity Using Engineered Tumour Cell Lines Expressing Either Murine or Human IDO1 or TDO2.
Pharmaceuticals (Basel)
; 15(9)2022 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36145311
5.
Effect of androgen deprivation therapy on serum levels of sclerostin, Dickkopf-1, and osteoprotegerin: a cross-sectional and longitudinal analysis.
Sci Rep
; 11(1): 14905, 2021 07 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34290287
6.
Efficacy against subcutaneous or intracranial murine GL261 gliomas in relation to the concentration of the vascular-disrupting agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), in the brain and plasma.
Cancer Chemother Pharmacol
; 73(3): 639-49, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24477604
7.
Labeling of oxidizable proteins with a photoactivatable analog of the antitumor agent DMXAA: evidence for redox signaling in its mode of action.
Neoplasia
; 12(9): 755-65, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20824052
8.
Neutrophil influx and chemokine production during the early phases of the antitumor response to the vascular disrupting agent DMXAA (ASA404).
Neoplasia
; 11(8): 793-803, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19649209
Resultados
1 -
8
de 8
1
Próxima >
>>